Other characteristics, including age (p = 0.06), sex (p = 0.22), Ki‐67 (p = 0.19), grade (p = 0.67), liver surgery history (p = 0.59), tumour burden (p = 0.83) and long‐acting octreotide therapy (p = 0.5), did not show significant differences between the pancreatic NENLM and rectal NENLM groups (Table 1). This evidence concerns the gene MKI67 and neoplasm.